KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Equity (2016 - 2025)

Historic Return on Equity for Amgen (AMGN) over the last 16 years, with Q3 2025 value amounting to 0.82%.

  • Amgen's Return on Equity rose 1900.0% to 0.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.82%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.68% for FY2024, which is 6800.0% down from last year.
  • According to the latest figures from Q3 2025, Amgen's Return on Equity is 0.82%, which was up 1900.0% from 0.97% recorded in Q2 2025.
  • Over the past 5 years, Amgen's Return on Equity peaked at 3.94% during Q2 2022, and registered a low of 0.57% during Q2 2024.
  • Its 5-year average for Return on Equity is 1.2%, with a median of 0.97% in 2023.
  • In the last 5 years, Amgen's Return on Equity soared by 32900bps in 2022 and then plummeted by -26300bps in 2023.
  • Amgen's Return on Equity (Quarter) stood at 0.79% in 2021, then surged by 127bps to 1.79% in 2022, then plummeted by -46bps to 0.97% in 2023, then tumbled by -37bps to 0.61% in 2024, then skyrocketed by 35bps to 0.82% in 2025.
  • Its Return on Equity was 0.82% in Q3 2025, compared to 0.97% in Q2 2025 and 0.98% in Q1 2025.